Immunotherapy for Guillain-Barré syndrome.

Autor(es): van Doorn Pieter A.; van Koningsveld Rinske


Imprenta: The Lancet. Neurology, v. 3, n. 2, p. 84, 2004


Identificador do objeto digital: 10.1016/S1474-4422(03)00660-4


Descritores: Guillain-Barre Syndrome - Proteins ; Guillain-Barre Syndrome - Antibodies ; Guillain-Barre Syndrome - Public health


Data de publicação: 2004